Market Place
Sourcing Support
Bal Pharma Consolidated June 2024 Net Sales at Rs 74.36 crore, up 5.64% Y-o-Y
23 Aug 2024 //
MONEYCONTROL
Bal Pharma consolidated net profit rises 225.00% in the June 2024 quarter
13 Aug 2024 //
BUSINESS-STANDARD
Karnataka pharma terms Union Budget as tepid with no mention of PLI scheme
24 Jul 2024 //
PHARMABIZ
Compliances-Certificate under Reg SEBI (DP) Reg 2018
04 Jul 2024 //
BSEINDIA
Bal Pharma Announcement under Regulation 30 LODR
28 Jun 2024 //
BSEINDIA
Bal Pharma Audited Financial Results_31.03.2024
28 May 2024 //
BSEINDIA
BAL Pharma showcased strong revenue growth for Q3 & 9MFY23
09 Feb 2023 //
PR NEWSWIRE
BAL Pharma announces resilient revenue growth for Q2 & H1FY23
17 Nov 2022 //
PR NEWSWIRE
Bal Pharma reports revenue growth of 36% YoY and EBITDA 46% YoY
12 Aug 2021 //
PHARMABIZ
Indian Govt impose anti-dump duty on bulk drug import of Gliclazide from China
17 Dec 2015 //
TWOFOUR INSIGHT
Bal Pharma gains after launching OTC medicine in Bangalore
10 Sep 2015 //
BUSINESS STANDARD
Bal Pharma Ltd launches OTC product `Eye Spa` in Bangalore
09 Sep 2015 //
EQUITY BULLS
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.